The purpose of this study is to test the safety and tolerability of using a new treatment called iC9-CAR.B7-H3 T cells in patients with ovarian, peritoneal or fallopian tube cancer.
Thank you for your interest, but this study will start enrolling soon.
United States (Nationwide)
Linda Van Le
LCCC - Clinical Trials
Clinical or Medical
Interventional
Cancer (Ovarian)
23-3044
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
